LEUKEMIAS
>
Latest News
TMLI Trial Shows Potential in Relapsed/Refractory Leukemia
By Jordyn Sava
October 2nd 2024
In an interview, Jeffrey Wong, MD, and Anthony Stein, MD, provided an in-depth discussion on a phase 2 trial of total marrow and lymphoid irradiation with cyclophosphamide and etoposide in high-risk acute leukemia.
Atypical Chronic Myeloid Leukemia: A Rare Disease With Poor Prognosis
September 18th 2024
Latest CME Events & Activities
6th Annual Precision Medicine Symposium: An Illustrated Tumor Board
October 18-19, 2024
Register Now!
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
